Anastomosis
|
disease |
|
Acquired Abnormality
|
155
|
2
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Disease Exacerbation
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Finding
|
166
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Gastrointestinal Neoplasms
|
group |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
182
|
3
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Prolactinoma
|
disease |
Neoplasms; Nervous System Diseases; Endocrine System Diseases
|
Neoplastic Process
|
187
|
6
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2019 |
Substance Use Disorders
|
group |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
218
|
16
|
0.020 |
None |
1.000 |
2 |
|
1998 |
2004 |
Uveitis
|
disease |
Eye Diseases
|
Disease or Syndrome
|
247
|
43
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Cone-Rod Dystrophy 2
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases
|
Disease or Syndrome
|
254
|
51
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Uric acid measurement (procedure)
|
phenotype |
|
Laboratory Procedure
|
264
|
1463
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Polycystic Kidney, Autosomal Dominant
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
280
|
35
|
0.020 |
None |
1.000 |
2 |
|
2019 |
2019 |
Hereditary Diffuse Gastric Cancer
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
312
|
119
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Medullary carcinoma of thyroid
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
330
|
71
|
0.020 |
None |
1.000 |
2 |
|
2001 |
2018 |
Headache
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
338
|
75
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Pheochromocytoma
|
disease |
Neoplasms
|
Neoplastic Process
|
344
|
186
|
0.020 |
None |
1.000 |
2 |
|
1992 |
2000 |
Adrenal Gland Pheochromocytoma
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
416
|
50
|
0.020 |
None |
1.000 |
2 |
|
1992 |
2000 |
Malignant mesothelioma
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
420
|
12
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Gastric Adenocarcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
453
|
235
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Rectal Carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
472
|
112
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2019 |
Neuroendocrine Tumors
|
group |
Neoplasms
|
Neoplastic Process
|
491
|
20
|
0.040 |
None |
1.000 |
4 |
|
2017 |
2019 |
Carcinoma breast stage IV
|
disease |
|
Neoplastic Process
|
573
|
14
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |
Diarrhea
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
632
|
63
|
0.020 |
None |
1.000 |
2 |
|
2007 |
2017 |
Intelligence
|
phenotype |
Behavior and Behavior Mechanisms
|
Mental Process
|
645
|
2093
|
0.100 |
None |
1.000 |
4 |
7
|
2017 |
2019 |
Chronic kidney disease stage 5
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
666
|
194
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Complete Trisomy 21 Syndrome
|
disease |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
669
|
77
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Down Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
766
|
80
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Stomach Neoplasms
|
group |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
820
|
55
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |